期刊
CELLS
卷 11, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/cells11121937
关键词
gene nomenclature; HGNC; fragile X syndrome; FMR1; FRAXA
类别
资金
- National Human Genome Research Institute (NHGRI) [U24HG003345]
- Wellcome Trust [208349/Z/17/Z]
- Wellcome Trust [208349/Z/17/Z] Funding Source: Wellcome Trust
This commentary responds to a recent article by Herring et al. discussing the eradication of the offensive term "retardation" from gene naming. The commentary outlines the actions taken by the HUGO Gene Nomenclature Committee (HGNC) to remove this term from gene names and highlights the latest naming changes made in collaboration with the authors and the European Fragile X Network.
This commentary is written in response to the recent article from Herring et al., discussing the eradication of the offensive term retardation from gene nomenclature. We discuss the work of the HUGO (Human Genome Organisation) Gene Nomenclature Committee (HGNC) and outline the steps already taken to remove this term from our gene names. We also highlight the latest nomenclature changes made as a result of discussions with the authors and agreement with the European Fragile X Network.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据